SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-010090
Filing Date
2017-08-31
Accepted
2017-08-31 09:00:27
Documents
14
Period of Report
2017-08-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31493
2 ex99-1.htm EX-99.1 12507
3 ex99-1_001.jpg GRAPHIC 57918
4 ex99-1_002.jpg GRAPHIC 120669
5 ex99-1_003.jpg GRAPHIC 60332
6 ex99-1_004.jpg GRAPHIC 79091
7 ex99-1_005.jpg GRAPHIC 75753
8 ex99-1_006.jpg GRAPHIC 62786
9 ex99-1_007.jpg GRAPHIC 66958
10 ex99-1_008.jpg GRAPHIC 52358
11 ex99-1_009.jpg GRAPHIC 71491
12 ex99-1_010.jpg GRAPHIC 73359
13 ex99-1_011.jpg GRAPHIC 43942
14 ex99-1_012.jpg GRAPHIC 63898
  Complete submission text file 0001493152-17-010090.txt   1187568
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 171062160
SIC: 2834 Pharmaceutical Preparations